Optimizing Lung SBRT Dose while Accounting for Histology Ensures Optimal Local Control for Inoperable Stage I Non-Small Cell Lung Cancer: Can Higher Biologically Equivalent Dose Overcome Size and SUV?

Autor: K.L. Stephans, C.A. Reddy, N.M. Woody, P. Qi, G.M. Videtic
Rok vydání: 2022
Předmět:
Zdroj: International Journal of Radiation Oncology*Biology*Physics. 114:S166
ISSN: 0360-3016
DOI: 10.1016/j.ijrobp.2022.07.661
Databáze: OpenAIRE